Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator System
Figure 2
Ciglitazone decreases chemotaxis in MCF-10A (a) and MCF-10CA1 cells (b). Chemotaxis to either BSA (1 mg/mL fatty-acid free BSA) or to EGF (5 ng/mL EGF in 1 mg/mL fatty acid free BSA) was performed as detailed under Section 2. Each condition was done in triplicate. Values represent total number of cells per well + SD .
